Receptor-linked degradation of 125I-insulin is mediated by internalization in isolated rat hepatocytes. by Gorden, P. et al.
THE YALE JOURNAL OF BIOLOGY AND MEDICINE 55 (1982), 101-112
Receptor-Linked Degradation of 125I-Insulin Is Mediated
by Internalization in Isolated Rat Hepatocytes
PHILLIP GORDEN, M.D. a,b PIERRE FREYCHET, M.D.,c
JEAN-LOUIS CARPENTIER, M.D.,b BERTRAND CANIVET, M.D.,b
AND LELIO ORCI, M.D.b
aDiabetes Branch, National Institute ofArthritis, Diabetes, and
Digestive and Kidney Diseases, National Institutes ofHealth, Bethesda,
Maryland; bInstitute ofHistology andEmbryology, University ofGeneva,
Geneva, Switzerland; cInstitut National de la Sante et de
la Recherche Medicale, U-145, Faculty ofMedicine (Pasteur),
Nice, France
Received March 18, 1982
When hepatocytes were freshly isolated from rat liver and incubated for various periods of
time at 37 °C, the media from the incubation, when completely separated from the cells, ac-
tively degraded '251-insulin. This soluble protease activity was strongly inhibited by bacitracin
but was unaffected by the lysosomatropic agent ammonium chloride (NH4Cl). When hepato-
cytes were incubated with 1251-insulin at 37°C in the presence or absence of 8 mM NH4C1 the
ligand initially bound to the plasma membrane and was subsequently internalized as a function
of time. When hepatocytes were incubated at 37°C for 30 minutes with '211-insulin in the
presence of bacitracin and NH4C1 or bacitracin alone and the cells were washed, diluted, and
the cell-bound radioactivity allowed to dissociate, the percent intact 'III-insulin in the cell pellet
and in the incubation media was greater in the presence of NH4Cl at each time point of incu-
bation. Under these same conditions a higher proportion of the cell-associated radioactivity
was internalized and a higher proportion was associated with lysosomes.
The data suggest that receptor-mediated internalization is required for insulin degradation
by the cell, and that this process, at least in part, involves lysosomal enzymes. Furthermore, the
data demonstrate that internalization is not blocked by the presence of bacitracin or NH4CI in
the incubation media, but that degradation is inhibited.
INTRODUCTION
The liver is the major organ involved in the degradation of insulin in vivo. Insulin
degradation in the isolated perfused rat liver is consistent with a receptor-linked pro-
cess [1,2] and in intact hepatocytes, in vitro, kinetic data suggest that insulin
degradation is receptor-linked [3]. For the most part, however, studies of insulin
degradation, in vitro, have not considered the intact cell but have been carried out in
soluble components of cells [4] or membranes [5], or in homogenates [6-9]. While it
is clear that potent insulin-degrading activity is present in these preparations, there is
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no evidence that this soluble degradative activity is receptor-linked. In fact,
analogues of insulin with very low receptor binding affinity inhibit at least some
forms of soluble degradation [5,10]; the process may be unrelated to receptor con-
centration [11], and degradation may occur when binding is blocked by insulin
receptor antibodies [12]. Thus, in order to study true cell-related degradation it is
necessary to minimize this soluble degradative activity with a protease inhibitor or
by some other means.
Wehave shown that following initial binding to the plasmamembrane, 125I-insulin
is internalized in isolated rat hepatocytes and is preferentially localized intracellu-
larly to membrane-bounded structures with the morphologic characteristics of lyso-
somes [13,14]. On the basis of these morphologic studies we have proposed that
receptor-linked insulin degradation in isolated hepatocytes is mediated by receptor-
linked internalization in these cells [13,14].
In the present study we have used combined morphological and biochemical
probes to investigate the degradation and compartmentalization of 1251-insulin at
physiological temperatures in freshly isolated rat hepatocytes.
MATERIALS AND METHODS
Cells and Reagents
Hepatocytes were isolated from six- to eight-week-old Wistar rats fed ad libitum
by a modification ofthe method ofSeglen [15] as previously described [14]. Buffers,
1251-insulin, and other reagents were exactly as previously described [14].
Incubation Conditions
Hepatocytes at a final concentration of 1 x 106 cells/ml were incubated in dupli-
cate in 0.5 ml ofmodified Krebs-Ringer Bicarbonate buffer (KRB) that contained 30
mg/ml bovine serum albumin (BSA, Fraction V), 0.5 nM (3 ng/ml) 1251-insulin (spe-
cific activity = 250 ,uCi/yig) at 37°C for varying time periods. Where indicated,
the buffer was supplemented with bacitracin, ammonium chloride, or both, and the
pH was adjusted to 7.7.
At the end ofappropriate periods of incubation, cells were separated from the in-
cubation media. The cells were analyzed by quantitative electron-microscopic (EM)
autoradiography, extracted for gel filtration, and the media were analyzed by gel
filtration. These studies were carried out as previously described [13,14,16] (for
specific variations, see legends to Figs. 1-6).
Liver Membrane Assay
Insulin integrity following exposure to media was assessed by measuring the bind-
ing ability of 1251-insulin to purified rat liver plasma membranes (step 15 of Neville)
[17]. The binding assay was carried out as follows: aliquot samples from control and
experimental media were incubated for 60 minutes at 37°C with liver membranes
(0.2 mg protein/ml) in Krebs-Ringer phosphate buffer, pH 7.5, containing 2 percent
BSA and 0.8 mg/ml bacitracin; non-specific binding was determined in parallel by
measuring the binding of "25I-insulin in the presence of 60Atg/ml unlabeled insulin.
Membranes were separated from the incubation media as previously described [5].
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RESULTS
Inhibition ofInsulin Degradation in Hepatocytes by Bacitracin
and Ammonium Chloride
In previous studies using purified liver membranes and isolated rat hepatocytes, it
has been shown that a soluble insulin-degrading activity is released into the incuba-
tion medium [4,5]. This activity, as previously shown, was strongly inhibited by
bacitracin which presumably acts as a nonspecific protease inhibitor (Fig. 1). Am-
monium chloride, at the concentrations used for these experiments, had no effect on
this soluble form ofinsulin degradation (Fig. 1) and for the purposes ofthese experi-
ments we assume that any inhibitory effect of ammonium chloride is on a cell-
related process that most likely involves lysosomal stabilization [18-20].
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FIG. 1. Degradation of '25I-insulin by Incubation Media from Hepatocytes.
Hepatocytes 1 x 10' cells/ml were first incubated (without l25l-insulin) for
30 minutes at 37°C in KRB buffer containing 2.4 percent BSA or in the same buf-
fer supplemented with 6.4 mM ammonium chloride; pH was adjusted to 7.5
for each medium. Media and cells were then separated by centrifugation for
one minute at 50 x g and the insulin-degrading ability of each medium was
studied by incubating aliquots from cell-free media with '2II-insulin (1.7
ng/ml) for 30 and 60 minutes at 37°C. Controls consisted of the same
'25l-insulin preparation which was exposed for 30 and 60 minutes at 37°C to
each type of medium but without prior incubation of media with hepatocytes.
The data shown here are representative of three separate experiments. In-
sulin integrity following exposure to media was assessed by measuring the
binding of '25l-insulin to purified rat liver membranes [5].
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Quantitative EM-Autoradiographic Studies ofthe Binding of "25I-Insulin in
Hepatocytes in the Presence ofAmmonium Chloride
We have previously shown that when '25I-insulin is incubated with isolated hepa-
tocytes at 37°C in buffer supplemented with bacitracin, the ligand is initially bound
to the plasma membrane and progressively internalized as a function of time [13].
To determine whether labeled insulin bound to the plasma membrane is internalized
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FIG. 2. Autoradiographic Grain Distribution Histograms of the In-
cubation of '25l-insulin with Isolated Rat Hepatocytes. '25I-insulin
was incubated with hepatocytes 1 x 106 cells/ml in KRB buffer, pH 7.7,
supplemented with 8 mM ammonium chloride but without bacitracin at
37°C for the time periods shown. At theend ofthespecified periods ofin-
cubation, cells were separated from the buffer by centrifugation, fixed
with 4 percent glutaraldehyde in 0.1 M phosphate buffer, pH 7.4, for four
hours and transferred to0.1 M phosphate buffer, pH 7.4, until processed.
They were then processed for autoradiography and analyzed as shown.
The percent of total number of grains was plotted as a function of the
distance of the grain center from the plasma membrane. The progressive
rightward shift of the histogram profile indicates internalization of the
labeled insulin. In this experiment 100 to 150 photographs were made
for each time point shown. The 0 point refers to the plasma membrane
(PM).
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by the hepatocyte in the presence of 8 mM ammonium chloride, 125I-insulin was
incubated with hepatocytes at 37°C in the presence and absence of ammonium
chloride and the hepatocytes were fixed at appropriate times, processed and ana-
lyzed by quantitative EM-autoradiography. The initial binding and internalization
of the ligand were qualitatively similar in the presence and absence of ammonium
chloride (Figs. 2 and 3) and were also similar to studies carried out in the presence of
bacitracin [13] (Table 1).
We conclude from these experiments that ammonium chloride does not inhibit
either binding or internalization of the labeled ligand in the hepatocyte.
Though it has been shown for other ligands or other cell preparations that cell-
associated radioactivity is increased in the presence of lysosomal stabilizers [20,21],
we have been unable to consistently show this phenomenon in the present ex-
periments. We attribute this to variation in soluble degradative activity in different
preparations of isolated hepatocytes.
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FIG. 3. Autoradiographic Grain Distribution Histograms of the In-
cubation of 125I-insulin with Isolated Rat Hepatocytes. Exactly the
same format as shown in Fig. 2 except that buffer was neither sup-
plemented with ammonium chloride nor bacitracin. The concentration of
125I-insulin bound at each time point shown was very similar to the concen-
tration bound in the experiment shown in Fig. 2.
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Concentration of '25l-Insulin Cell Associated and Internalized in Isolated Rat Hepatocytes
Time (Minutes)
Condition 2 5 10 20 30 60
Buffer Cell-associated (pg/ml)a 68.4 119.1 143.7 134.7 118.8 81.0
Buffer Internalized (pg/ml)b 11.0 34.9 45.0 49.0 40.8 41.1
Buffer Cell-associated (pg/mi) 63.6 121.2 152.7 178.2 184.2 136.2
+
Bacitracin Internalized (pg/ml) 15.8 31.0 53.8 78.8 88.1 69.6
Buffer
+ Cell-associated (pg/ml) 66.6 133.2 184.2 200.4 208.8 187.8
Bacitracin
+ Internalized (pg/ml) 13.9 50.5 59.7 91.2 106.5 98.8
NH4CI
aConcentrations I'll-insulin cell associated
1251-insulin cell-associated
= concentration of '25l-insulin in incubation media x %7o
bConcentration '25l-insulin internalized = concentration of cell associated '25I-insulin x 7lo
'251-insulin internalized
Effect ofAmmonium Chloride on the Dissociation andDegradation of '25I-Insulin
Associated with Hepatocytes
When '25I-insulin was incubated with hepatocytes for 30 minutes at 37°C, the cells
were washed and the cell-bound radioactivity was allowed to dissociate. At each
time studied there was less dissociation of labeled material from the cell in the
presence of ammonium chloride (Tables 2 and 3).
Under these same conditions the proportion of intact labeled insulin associated
with the cell progressively declined as a function of dissociation time, and degraded
products progressively increased in a reciprocal fashion (Fig. 4). The cell-related
degradation process was markedly inhibited by the presence of ammonium chloride
in the incubation media. The proportion of degraded products appearing in the in-
cubation media was inhibited by ammonium chloride at each time of dissociation.
Quantitative EM-Autoradiographic Studies During Dissociation of '25I-Insulin
from Hepatocytes
Hepatocytes were incubated with l25l-insulin in the presence of ammonium chlor-
ide and bacitracin in the incubation media for 30 minutes at 37°C; the cells were
TABLE 2
Dissociation (by Dilution) of '25l-Insulin from Isolated Hepatocytes Incubated at 37°C
Percentage of Initial Binding (mean SEM of four experiments)
Condition
Time of Dissociation Buffer + Bacitracin
(Minutes) Buffer + Bacitracin + NH4Cl p
5 81.0 + 2.7 78.2 + 3.4 N.S.
10 69.5 + 1.9 69.2 i 4.9 N.S.
20 54.5 A 1.3 61.5 + 3.7 N.S.
30 43.0 A 1.5 52.7 + 4.4 0.05
60 23.3 + 1.8 38.0 t 3.7 <0.01
90 15.0 X 0.9 31.2 + 3.9 <0.005
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TABLE 3
Dissociation (by Dilution) of '25l-Insulin from Isolated Hepatocytes Incubated at 37°C
Percentage of Initial Binding (mean A SEM of four experiments)
Condition
Time ofDissociation
(Minutes) Buffer Buffer + NH4Cl p
5 58.1 + 5.7 58.4 + 5.5 N.S.
10 44.7 X 3.5 52.7 A 6.0 N.S.
20 29.7 X 1.1 48.0 + 4.1 <0.005
30 23.7 + 1.1 39.7 s 1.9 <0.0005
60 13.7 + 2.3 28.0 f 4.2 <0.02
90 8.2 - 0.5 21.2 + 2.0 <0.0005
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FIG. 4. Analysis of Radioactivity as a Function of Dissociation Time. '251-insulin was in-
cubated with hepatocytes for 30 minutes at 37°C in KRB-albumin buffer (pH 7.7) and 0.8 mg/ml of
bacitracin. At the end of the association period a large excess of unlabeled insulin was added to the
media to prevent rebinding of the labeled insulin, and dissociation was allowed to proceed. At the
end of the specified periods of dissociation, the cells were separated from the media by centrifuga-
tion and extracted as previously described [14]. The cell extract and the media extract were then
filtered on G-50 Sephadex as described 1141. Percent intact insulin refers to the percent ofthe labeled
insulin eluting in the region ofthe insulin marker, and the percent degraded refers to the proportion
eluting as low molecular weight peptides. An additional peak corresponding to void volume (not
shown) represented 5 to 15 percent of the eluted radioactivity and was the same in both the am-
monium chloride and control incubations. The percent intact insulin as shown here, and the percent
of the labeled material rebindable to fresh cells, were in good agreement (data not shown). The ex-
periment shown here is representative of three separate incubations and the elution profiles of the
individual column runs differed by less than 15 percent. The experiment shown here is represen-
tative of three separate incubations.
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washed, resuspended, and further incubated. At appropriate times, cells were fixed
and processed for EM-autoradiography. In experiments where ammonium chloride
was omitted there was insufficient autoradiographic reaction for analysis.
Under the conditions of this experiment the percent ligand internalized increased
as a function of dissociation time and reached up to 69 percent of the cell-associated
grains (Figs. 5 and 6). Furthermore, as dissociation proceeded, a higher proportion
of grains was associated with lysosomes (Fig. 6).
DISCUSSION
Soluble fractions have been the most frequently utilized preparation to study in-
sulin degradation in liver [4-9]. Both protease and transhydrogenase activity have
been demonstrated in liver homogenates, purified liver membranes, and freshly
isolated cells. The mechanisms, however, whereby these reactions occur phys-
iologically in the intact cell are unclear. These and other studies demonstrate
that binding of the ligand is not a prerequisite for this type of degradation to occur.
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FIG. 5. Autoradiographic Grain Distribution Histograms of 'III-insulin In-
cubated at 370C for 30 minutes in KRB-Albumin Buffer (pH 7.7), in 0.8
mg/mi Bacitracin and 8 mM Ammonium Chloride. At the end of the
30-minute association period, cells were diluted 100-fold and the radioactivity
was allowed to dissociate. The cell pellet was then fixed and processed for
autoradiography at each time shown. The normalized number of grains is
plotted as a function of the distance of the grain center from the plasma mem-
brane, expressed in nanometers (NM). The shaded bar represents the plasma
membrane (PM). For the percent grains internalized at each time point of
dissociation, see Fig. 6. For the purpose of this analysis, grains appearing
±250 nm of the plasma membrane were considered to be associated with the
plasma membrane and grains appearing intracellularly beyond 250 nm were
considered to be internalized. In this experiment 100 to 150 photographs
were made for each time point shown. The 0 point refers to the plasma mem-
brane (PM).
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It was initially suggested by Mortimore and Tietze that a"trapping" step preceded
insulin degradation in the isolated perfused liver [1] and this was confirmed by Ter-
ris and Steiner [2]. Terris and Steiner further showed in the isolated hepatocyte that
the degradation of insulin was linked to the binding of the ligand [3]. We have
demonstrated in isolated hepatocytes that the binding ofinsulin to cell surface recep-
tors is followed rapidly by the internalization of the ligand and that the internalized
ligand preferentially associates with lysosome-like structures [13,14].
In the present study we have shown that NH4CI, an agent presumed to impair
lysosomal function, inhibits insulin degradation by intact hepatocytes but has no ef-
fect on soluble degrading activity. At least one mechanism by which agents such as
NH4C1 are thought to exert their effect is by increasing intralysosomal pH; this
should decrease the activity of proteolytic enzymes with an acid pH optimum. Re-
cent studies by McKanna et al. suggest that the epidermal growth factor hormone
receptor complex remains intact in the lysosomal membrane in the presence of
amines, while in the absence of these agents the ligand appears in the lumen of the
lysosome presumably accessible to lysosomal enzymes [22]. Our data are most
consistent with a similar process for insulin associated with hepatocyte lysosomes.
Fluorescent probes of EGF and insulin suggested that both bacitracin and primary
amines inhibited the internalization of insulin and EGF [23,24]. If this were true, it
would suggest a different mechanism to explain our results. However, the work
presented here, as well as our previous studies [13,14,25] demonstrate that neither
bacitracin nor the amines inhibit internalization of EGF or insulin and this has been
more recently confirmed by Haigler et al. [26]. These potentially conflicting results
demonstrate the importance of direct morphologic studies using different types of
probes. These data do not exclude the possibility that the lysosomotropic agents
have other effects such as inhibiting the egress of the ligand from the lysosome to
another degradative site or other functions yet uncharacterized.
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FIG. 6. Internalization and Lysosomal Association of 1251I-insulin in Isolated Hepatocytes as a Function
of Incubation Time. These data were derived from Fig. 5. The percentage of grains associated with
lysosomes was determined by a probability circle method as previously described [14]. For further details
and representative photographs of cells see [14,39,40].110 GORDEN ET AL.
Kahn and Baird [27] and Olefsky et al. [28] have shown in adipocytes that, at
370C, the rate or amount of labeled material dissociated is inversely proportional to
association time; we have shown the same for insulin binding to hepatocytes [141. In
both the adipocyte [27] and the hepatocyte [14], as a function ofdissociation time, a
higher proportion of labeled material released by the cell is degraded. Though little
work has been done to implicate the lysosome in insulin degradation [29,30], follow-
ing the demonstration that internalized insulin associates with lysosomes [14], at
least four other groups have confirmed that lysosomotropic agents inhibit cell-
related insulin degradation [21,31-33].
The results of these studies on insulin degradation are remarkably similar to the
binding, internalization, and lysosomal degradation of epidermal growth factor by
human fibroblasts [20,25,34], to human choriogonadotropin degradation by*
gonadotropin binding cells [35-37], and to low-density lipoprotein degradation by
human fibroblasts [38]. Thus, the process described here for insulin degradation ap-
pears to be a general mechanism applicable to many diverse ligands that bind to
specific cell-surface receptors.
If receptor-linked insulin degradation is a physiologic process, receptor-linked in-
ternalization provides a simple mechanism for this process to occur. There are a
number of implications of this process that have not generally been considered. The
internalization of the ligand appears to occur by way of endocytosis. If this is true,
then the ligand is internalized into a membrane-bounded endocytotic vesicle which
in turn fuses with membrane-bounded lysosomes. The ligand may then be degraded
in the intact cell incubated at physiologic pH by a lysosomal process. The mor-
phological data demonstrating internalization and lysosomal association, coupled
with the biochemical data demonstrating inhibition of degradation by lysosoma-
tropic agents, is consistent with this process.
It is, therefore, possible that the physiologic mechanism of degradation of poly-
peptide hormones and growth factors occurs by binding to specific cell surface
receptors, which induces endocytosis of the ligand into a membrane-bounded com-
partment. The ultimate degradative process need not be solely lysosomal; the endo-
cytotic vesicle could provide a mechanism to concentrate non-lysosomal proteolytic
enzymes.
Thus, it seems clear that lysosomal processes are involved in the degradation of
polypeptide hormones and growth factors, but it is as yet unclear how important
these processes are quantitatively relative to non-lysosomal proteases.
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